Trials / Completed
CompletedNCT00000241
Flupenthixol Decanoate in Methamphetamine Smoking - 1
Flupenthixol Decanoate in Methamphetamine Smoking
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 58 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 22 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flupenthixol |
Timeline
- Start date
- 1994-02-01
- Completion
- 1996-05-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000241. Inclusion in this directory is not an endorsement.